US 12280124
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
granted A61KA61K47/6811A61K47/6849
Quick answer
US patent 12280124 (Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K47/6811, A61K47/6849, A61K47/6889, A61P